HYACORP FINE®

Product Description

HYACORP FINE® is a high-purity, absorbable dermal filler formulated explicitly for medical professionals seeking effective skin rejuvenation solutions. This sterile, viscoelastic gel contains hyaluronic acid of non-animal origin, produced through advanced fermentation processes. The product integrates seamlessly with the dermal matrix, providing optimal volume restoration and enhanced skin hydration for patients requiring fine line correction.

HYACORP FINE® Dosage and Administration

Proper injection technique requires careful consideration of treatment area size and desired aesthetic outcomes. Medical professionals should implant HYACORP FINE® evenly throughout the medium dermis using the provided 30G needles. The injection volume varies according to patient needs, with visual confirmation ensuring adequate placement of the product.

Pre-treatment preparation involves thoroughly cleansing the injection sites with antiseptics and handling sterile instruments. Administration protocols recommend gradual product placement to prevent overcorrection, allowing for natural tissue accommodation between injection points.

Ingredient Information

Each 1ml syringe contains precisely measured active components optimized for dermal integration. The primary ingredient, hyaluronic acid sodium salt (14.0mg), provides the volumizing and hydrating properties essential for skin rejuvenation. Sodium chloride (6.9 mg) serves as the isotonic agent, ensuring proper osmotic balance within the treated areas.

Hyaluronic acid is derived from non-animal sources through controlled fermentation processes, thereby eliminating concerns regarding sensitivities to animal-derived proteins. All components meet pharmaceutical-grade standards, ensuring consistent quality across manufacturing batches.

Storage Instructions

HYACORP FINE® requires temperature-controlled storage between 2°C and 25°C, protecting the hyaluronic acid structure from degradation. Healthcare facilities must avoid freezing conditions, which can compromise product performance. Exposure to direct sunlight and extreme heat sources can alter the consistency of the gel, potentially affecting injection characteristics and results.

HYACORP FINE® Contraindications

• Scarring tendencies: Patients with hypertrophic or keloid scarring history demonstrate increased risk for adverse healing responses
• Allergic sensitivities: Known allergies to hyaluronic acid or gram-positive bacteria represent contraindications due to potential severe reactions
• Active infections: Skin infections or inflammatory processes in treatment areas require complete resolution before dermal filler procedures
• Anticoagulant therapy: Patients receiving blood-thinning medications face increased bleeding and bruising risks
• Special populations: Pregnancy, breastfeeding, and patients under 18 years represent contraindications due to insufficient safety data

HYACORP FINE® Precautions and Warnings

Intravascular injection presents serious complications, including tissue necrosis and embolism formation. Practitioners must exercise extreme caution during needle placement, avoiding blood vessel penetration through proper anatomical knowledge and injection technique.

Pre-treatment patient counseling should address medication interactions, particularly aspirin, steroids, and high-dose vitamin E supplementation. These substances increase bleeding tendencies and may compromise treatment outcomes.

HYACORP FINE® Manufacturer and Regulatory Information

Bioscience GmbH, Germany, manufactures HYACORP FINE® under strict quality control standards ensuring consistent product performance. CE marking under Medical Device Directive 93/42/EEC confirms European regulatory compliance and safety standards.

The complete product package includes one 1ml pre-filled syringe, two sterile 30G needles, and comprehensive product documentation. Healthcare providers receive detailed technical information supporting safe and effective clinical use.